BACKGROUND: One of the causes of Parkinson's disease is mutations in the PARK2 gene. Deletions and duplications of single exons or exon groups account for a large proportion of the gene mutations. Direct detection of these mutations can be used for the diagnosis of Parkinson's disease. METHODS: To detect these mutations, we developed an effective technique based on the real-time TaqMan PCR system, which allows us to evaluate the copynumbers of the PARK2 gene exons by comparing the intensity of the amplification signals from some exon of this gene with that of the beta-globin gene (the internal control). RESULTS: We analyzed rearrangements in exons 1-12 of the PARK2 gene in 64 patients from Russia with early-onset Parkinson's disease. The frequency of these mutations in our patients was 14%. CONCLUSION: We have developed a simple, accurate, and reproducible method applicable to the rapid detection of exon rearrangements in the PARK2 gene. It is suitable for the analysis of large patient groups, and it may become the basis for a diagnostic test.
BACKGROUND: One of the causes of Parkinson's disease is mutations in the PARK2 gene. Deletions and duplications of single exons or exon groups account for a large proportion of the gene mutations. Direct detection of these mutations can be used for the diagnosis of Parkinson's disease. METHODS: To detect these mutations, we developed an effective technique based on the real-time TaqMan PCR system, which allows us to evaluate the copynumbers of the PARK2 gene exons by comparing the intensity of the amplification signals from some exon of this gene with that of the beta-globin gene (the internal control). RESULTS: We analyzed rearrangements in exons 1-12 of the PARK2 gene in 64 patients from Russia with early-onset Parkinson's disease. The frequency of these mutations in our patients was 14%. CONCLUSION: We have developed a simple, accurate, and reproducible method applicable to the rapid detection of exon rearrangements in the PARK2 gene. It is suitable for the analysis of large patient groups, and it may become the basis for a diagnostic test.
Authors: R Hilker; C Klein; M Ghaemi; B Kis; T Strotmann; L J Ozelius; O Lenz; P Vieregge; K Herholz; W D Heiss; P P Pramstaller Journal: Ann Neurol Date: 2001-03 Impact factor: 10.422
Authors: C B Lücking; A Dürr; V Bonifati; J Vaughan; G De Michele; T Gasser; B S Harhangi; G Meco; P Denèfle; N W Wood; Y Agid; A Brice Journal: N Engl J Med Date: 2000-05-25 Impact factor: 91.245
Authors: K Hedrich; M Kann; A J Lanthaler; A Dalski; C Eskelson; O Landt; E Schwinger; P Vieregge; A E Lang; X O Breakefield; L J Ozelius; P P Pramstaller; C Klein Journal: Hum Mol Genet Date: 2001-08-01 Impact factor: 6.150
Authors: M Maruyama; T Ikeuchi; M Saito; A Ishikawa; T Yuasa; H Tanaka; S Hayashi; K Wakabayashi; H Takahashi; S Tsuji Journal: Ann Neurol Date: 2000-08 Impact factor: 10.422
Authors: Jan P Schouten; Cathal J McElgunn; Raymond Waaijer; Danny Zwijnenburg; Filip Diepvens; Gerard Pals Journal: Nucleic Acids Res Date: 2002-06-15 Impact factor: 16.971
Authors: T Kitada; S Asakawa; N Hattori; H Matsumine; Y Yamamura; S Minoshima; M Yokochi; Y Mizuno; N Shimizu Journal: Nature Date: 1998-04-09 Impact factor: 49.962
Authors: N Abbas; C B Lücking; S Ricard; A Dürr; V Bonifati; G De Michele; S Bouley; J R Vaughan; T Gasser; R Marconi; E Broussolle; C Brefel-Courbon; B S Harhangi; B A Oostra; E Fabrizio; G A Böhme; L Pradier; N W Wood; A Filla; G Meco; P Denefle; Y Agid; A Brice Journal: Hum Mol Genet Date: 1999-04 Impact factor: 6.150
Authors: Andrew West; Magali Periquet; Sarah Lincoln; Christoph B Lücking; David Nicholl; Vincenzo Bonifati; Nina Rawal; Thomas Gasser; Ebba Lohmann; Jean-François Deleuze; Demetrius Maraganore; Allan Levey; Nick Wood; Alexandra Dürr; John Hardy; Alexis Brice; Matt Farrer Journal: Am J Med Genet Date: 2002-07-08
Authors: E M Valente; A R Bentivoglio; P H Dixon; A Ferraris; T Ialongo; M Frontali; A Albanese; N W Wood Journal: Am J Hum Genet Date: 2001-03-07 Impact factor: 11.025
Authors: Peter Bauer; Beate Winner; Rebecca Schüle; Claudia Bauer; Veronika Häfele; Ute Hehr; Michael Bonin; Michael Walter; Kathrin Karle; Thomas M Ringer; Olaf Riess; Jürgen Winkler; Ludger Schöls Journal: Neurogenetics Date: 2008-09-12 Impact factor: 2.660
Authors: Andrey V Khrunin; Irina N Filippova; Aydar M Aliev; Tat'yana V Tupitsina; Petr A Slominsky; Svetlana A Limborska Journal: Mol Cytogenet Date: 2016-04-19 Impact factor: 2.009